Japanese
English
- 有料閲覧
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
患者は76歳,女性.呼吸苦を主訴に当科入院した.現症では血圧92/62mmHg,心雑音第2肋間胸骨左縁2/6度の収縮期雑音,II音の固定性分裂(+)あり,胸部単純X線写真では著明な心拡大,肺うっ血,肺動脈の拡大,心電図は完全右脚ブロック,心エコー検査では径29mmの心房中隔の欠損孔,右室拡大,推定肺動脈圧88.8mmHgより心房中隔欠損症に伴う肺高血圧症,心不全と診断した.心臓カテーテル検査では心房レベルでの左右シャント,血中酸素飽和度の上昇を認めた.肺動脈の拡張能をみる試験には純酸素,一酸化窒素(NO)吸入試験がある.また,sildenafilにもNOと同様の肺血管拡張作用を認めていることから,肺血管の拡張効果,有用性の比較検討のため酸素吸入(O2)とsildenafil(Si)負荷試験を施行した.その結果,PVRはO2後68.6%,Si後51.8%低下し,PVR/SVR ratioはO2後66.6%,Si後55.5%低下した.sildenafilの内服は酸素吸入とほぼ同等に肺高血圧を低下させた.高齢者ASD,PH患者においても肺血管の拡張能の評価に用うることが示唆された.
In a case of a 76-year-old female with atrial septal defect complicated by pulmonary hypertension, the effects of oxygen inhalation (O2) and sildenafil on pulmonary vessel compliance were compared. Pulmonary vessel compliance can be assessed by conducting an inhalation test using pure O2 or nitric oxide(NO). Since sildenafil dilates pulmonary vessels in a manner similar to dilation induced by NO, we investigated the effects of sildenafil on pulmonary hypertension. The results confirmed that O2 and sildenafil lowered pulmonary vascular resistance (PVR) by 68.6 and 51.8%, respectively, and decreased the PVR/systemic vascular resistance (SVR) ratio by 66.6 and 55.5%, respectively. Because the results of the present study showed that sildenafil lowered pulmonary hypertension to a degree comparable to that induced by oxygen inhalation, it can be used to assess pulmonary vessel compliance even in elderly patients with pulmonary hypertension.
Copyright © 2006, Igaku-Shoin Ltd. All rights reserved.